Hormel Foods Corp. (HRL) 10-K Summary: Fiscal Year Ended October 27, 2024
Business Context and Reporting Period
Hormel Foods Corporation is a global branded food company operating in three segments: Retail, Foodservice, and International. The company manufactures and distributes meat, nuts, and other food products across more than 80 countries. This filing covers the fiscal year ended October 27, 2024 (52 weeks). The company reported approximately $11.9 billion in annual revenue and employs roughly 20,000 people, with over 90% located in the U.S.
Key Financial Metrics
| Metric | Fiscal 2024 | Fiscal 2023 | Change |
|---|---|---|---|
| Net Sales | $11.92 billion | $12.11 billion | (1.6)% |
| Gross Profit | $2.02 billion | $2.00 billion | 1.1% |
| Gross Margin | 17.0% | 16.5% | +50 bps |
| Net Earnings | $805.0 million | $793.6 million | 1.4% |
| Diluted EPS | $1.47 | $1.45 | 1.4% |
| Adjusted Diluted EPS | $1.58 | $1.61 | (1.9)% |
| Operating Cash Flow | $1.27 billion | $1.05 billion | 20.9% |
| Capital Expenditures | $256 million | $270 million | (5.2)% |
| Total Debt | $2.86 billion | $3.31 billion | (13.6)% |
| Cash & Equivalents | $742 million | $737 million | 0.7% |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 1.6% year-over-year. The Retail segment declined 4.8% due to pricing declines in whole bird/commodity turkey and softness in Convenient Meals & Proteins. The International segment declined 2.8% due to lower commodity exports and sales in China. These declines were partially offset by a 5.6% increase in the Foodservice segment.
- Profitability: Despite lower sales, Net Earnings increased 1.4% to $805 million, driven by improved segment profit (up 1.8%) and favorable interest/investment income. Gross margin expanded to 17.0% due to pricing actions and cost savings from the "Transform and Modernize" (T&M) initiative.
- Segment Performance:
- Retail: Segment profit declined 2.6% to $562.8 million, impacted by lower sales and higher SG&A, though partially offset by lower logistics costs and the absence of a $28.4 million impairment charge recorded in the prior year.
- Foodservice: Segment profit remained flat (up 0.1%) at $596.3 million. Higher sales and lower logistics costs were offset by lower margins in certain categories and higher SG&A.
- International: Segment profit surged 66.7% to $92.1 million, driven by minority investment contributions, improved mix in China, and favorable export product mix.
- Divestiture: The company sold Hormel Health Labs, LLC in Q4 2024, recognizing a pre-tax gain of $3.9 million.
Guidance, Outlook, and Risks
Fiscal 2025 Outlook:
- Organic Net Sales: Expected to grow 1% to 3%.
- Diluted EPS: Projected between $1.51 and $1.65.
- Adjusted Diluted EPS: Projected between $1.58 and $1.72.
- Dividend: Annual dividend increased to $1.16 per share (3% increase), marking the 59th consecutive year of increases.
- Capital Expenditures: Estimated at $275 million to $300 million.
Management Commentary & Risks:
- Transform and Modernize (T&M): The company expects to realize a benefit to net earnings from this initiative in fiscal 2025. Fiscal 2024 saw significant investment in this multi-year program.
- Production Disruptions: Fiscal 2024 Planters sales were negatively impacted by production disruptions at the Suffolk, Virginia facility. Management expects recovery to historical levels once supply normalizes, though prolonged issues could trigger an impairment charge on the $675 million trade name.
- Antitrust Litigation: The company settled three antitrust matters (Pork, Red Meat Wages, Poultry Wages) in fiscal 2024, recording settlements totaling approximately $21.9 million in SG&A expenses.
- Commodity Costs: Raw material costs for pork, beef, and nuts are anticipated to be above historical levels in 2025, while feed costs are expected to be lower.
- Key Risks: Deteriorating macroeconomic conditions, inflationary pressures, Highly Pathogenic Avian Influenza (HPAI) impacts on turkey supply, and potential impairment of the Planters trade name if production disruptions persist.
Investor Verification Checklist
- Planters Recovery: Verify the timeline for the resolution of production disruptions at the Suffolk, Virginia facility and the potential impact on the $675 million Planters trade name valuation.
- T&M Initiative ROI: Monitor the realization of cost savings and operating profit improvements from the Transform and Modernize initiative in fiscal 2025.
- Commodity Hedging: Review the effectiveness of hedging programs given the expectation of higher pork, beef, and nut costs in the coming year.
- Antitrust Exposure: Confirm the final status of the settled antitrust litigation and assess any remaining exposure from non-class direct-action plaintiffs.
- International Growth: Evaluate the sustainability of the 66.7% profit growth in the International segment, particularly regarding China operations and minority investments.